Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : SENS-01
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Undisclosed
Deal Size : $30.0 million
Deal Type : Series A Financing
Sensorium Raises $30M in Series A Round To Probe Plants, Fungi For Psychoactive Natural Products
Details : SENS-01 shows promise to deliver rapid therapeutic effect for treating anxiety. Sensorium is developing SENS-01 as a rapid-acting and well-tolerated therapeutic for patients with anxiety and depression.
Product Name : SENS-01
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
August 11, 2022
Lead Product(s) : SENS-01
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Undisclosed
Deal Size : $30.0 million
Deal Type : Series A Financing
Reset All
